Six ingredients or fewer Three peptides, two carriers, one preservative
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores
Common symptoms include: Chronic fatigue Dizziness or light-headedness Pale or yellowing skin Shortness of breath Mood swings, anxiety, or depression Tingling in hands and feet Brain fog or memory difficulties When these symptoms occur alongside hair loss, a B12 test is highly recommended
The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use
Antioxidant enzymes such as catalase, glutathione peroxidase, and MnSOD remain vital to cellular defense, and FOXO4-DRI has been considered a tool to examine senescence while maintaining these protective systems
functional and/or structural moieties such as carbohydrates, fats, proteins or peptides, antibodies, receptors, hormones, cytotoxic substances, marker substances, dyes, radioactive labels, immunomodulatory agents, drugs, carriers, targeting or signalling substances, etc